Mutagenesis-Based Characterization and Improvement of a Novel Inclusion Body Tag
dc.contributor.author | Jong, Wouter S.P. | |
dc.contributor.author | ten Hagen-Jongman, Corinne M. | |
dc.contributor.author | Vikström, David | |
dc.contributor.author | Dontje, Wendy | |
dc.contributor.author | Abdallah, Abdallah | |
dc.contributor.author | de Gier, Jan Willem | |
dc.contributor.author | Bitter, Wilbert | |
dc.contributor.author | Luirink, Joen | |
dc.date.accessioned | 2020-02-06T12:23:26Z | |
dc.date.available | 2020-02-06T12:23:26Z | |
dc.date.issued | 2020-01-10 | |
dc.date.submitted | 2019-09-26 | |
dc.identifier.citation | Jong, W. S. P., ten Hagen-Jongman, C. M., Vikström, D., Dontje, W., Abdallah, A. M., de Gier, J.-W., … Luirink, J. (2020). Mutagenesis-Based Characterization and Improvement of a Novel Inclusion Body Tag. Frontiers in Bioengineering and Biotechnology, 7. doi:10.3389/fbioe.2019.00442 | |
dc.identifier.doi | 10.3389/fbioe.2019.00442 | |
dc.identifier.uri | http://hdl.handle.net/10754/661419 | |
dc.description.abstract | Whereas, bacterial inclusion bodies (IBs) for long were regarded as undesirable aggregates emerging during recombinant protein production, they currently receive attention as promising nanoparticulate biomaterials with diverse applications in biotechnology and biomedicine. We previously identified ssTorA, a signal sequence that normally directs protein export via the Tat pathway in E. coli, as a tag that induces the accumulation of fused proteins into IBs under overexpression conditions. Here, we used targeted mutagenesis to identify features and motifs being either critical or dispensable for IB formation. We found that IB formation is neither related to the function of ssTorA as a Tat-signal sequence nor is it a general feature of this family of signal sequences. IB formation was inhibited by co-overexpression of ssTorA binding chaperones TorD and DnaK and by amino acid substitutions that affect the propensity of ssTorA to form an α-helix. Systematic deletion experiments identified a minimal region of ssTorA required for IB formation in the center of the signal sequence. Unbiased genetic screening of a library of randomly mutagenized ssTorA sequences for reduced aggregation properties allowed us to pinpoint residues that are critical to sustain insoluble expression. Together, the data point to possible mechanisms for the aggregation of ssTorA fusions. Additionally, they led to the design of a tag with superior IB-formation properties compared to the original ssTorA sequence. | |
dc.description.sponsorship | We would like to thank Elise Riesebos, Rosa Luirink, and Erik van Duijvenvoorde for excellent technical assistance. Olivier Fayet (LMGM, Toulouse, France) and Bernard Connolly (University of Newcastle, Newcastle upon Tyne, UK) are gratefully acknowledged for their contribution of plasmids and reagents. | |
dc.publisher | Frontiers Media SA | |
dc.relation.url | https://www.frontiersin.org/article/10.3389/fbioe.2019.00442/full | |
dc.relation.url | https://www.frontiersin.org/articles/10.3389/fbioe.2019.00442/pdf | |
dc.relation.url | https://www.frontiersin.org/articles/10.3389/fbioe.2019.00442/pdf | |
dc.rights | Archived with thanks to Frontiers in Bioengineering and Biotechnology | |
dc.rights | This file is an open access version redistributed from: https://www.frontiersin.org/articles/10.3389/fbioe.2019.00442/pdf | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Mutagenesis-Based Characterization and Improvement of a Novel Inclusion Body Tag | |
dc.type | Article | |
dc.contributor.department | Biological and Environmental Sciences and Engineering (BESE) Division | |
dc.contributor.department | Bioscience Core Lab | |
dc.contributor.department | Computational Bioscience Research Center (CBRC) | |
dc.contributor.department | Computer, Electrical and Mathematical Sciences and Engineering (CEMSE) Division | |
dc.contributor.department | NGS, qPCR and Single Cell Genomics | |
dc.contributor.department | Sanger and Third Generation Sequencing | |
dc.identifier.journal | Frontiers in Bioengineering and Biotechnology | |
dc.eprint.version | Publisher's Version/PDF | |
dc.contributor.institution | Abera Bioscience AB, Solna, Sweden | |
dc.contributor.institution | Department of Molecular Microbiology, Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Vrije Universiteit, Amsterdam, Netherlands | |
dc.contributor.institution | Xbrane Biopharma AB, Solna, Sweden | |
dc.contributor.institution | Department of Clinical Immunology and Rheumatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands | |
dc.contributor.institution | Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar | |
dc.contributor.institution | Department of Biochemistry and Biophysics, Center for Biomembrane Research, Stockholm University, Stockholm, Sweden | |
dc.contributor.institution | Medical Microbiology and Infection Control, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands | |
kaust.person | Abdallah, Abdallah | |
dc.date.accepted | 2019-12-10 | |
refterms.dateFOA | 2020-02-06T12:24:20Z |
Files in this item
This item appears in the following Collection(s)
-
Articles
-
Biological and Environmental Science and Engineering (BESE) Division
For more information visit: https://bese.kaust.edu.sa/ -
Computational Bioscience Research Center (CBRC)
-
Bioscience Core Lab
-
Computer, Electrical and Mathematical Science and Engineering (CEMSE) Division
For more information visit: https://cemse.kaust.edu.sa/